Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
KALSIOM SAS logo — Targeting calcium signaling to cure auto-immune diseases

KALSIOM SAS

Targeting calcium signaling to cure auto-immune diseases

Founded 2020 France France 5 employees Biotechnology, Health Care +1

General Information

Company Name KALSIOM SAS
Founded Year 2020
Location France France
Employees 5
Industries Biotechnology, Health Care, Health and Wellness
Social

BounceWatch is an independent company data service, not affiliated with KALSIOM SAS. To contact KALSIOM SAS, visit kalsiom.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does KALSIOM SAS compare?

A PDF of KALSIOM SAS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting KALSIOM SAS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About KALSIOM SAS

KALSIOM SAS is a biotech company that was founded in April 2020 and is based in Brest, France. The company's slogan "Targeting calcium signaling to cure auto-immune diseases" encapsulates its focus on discovering and developing first-in-class therapies to treat auto-immune disorders (AID) involving B-cell dysfunction, addressing a high medical need. KALSIOM is primarily concentrating on the development of first-in-class monoclonal antibodies that modulate calcium-signaling pathways in lymphocytes. As of now, there is no information available about the last investment and the last investment investors. This startup shows potential in addressing a critical aspect of biotechnology, with a clear focus on addressing unmet medical needs in the field of auto-immune disorders.

Business keywords: biotech, auto-immune diseases, B-cell dysfunction, monoclonal antibodies, calcium signaling, immunology, therapeutic antibodies, lymphocytes, immunotherapy, drug development, medical research, France, startup, investing

No funding data available for KALSIOM SAS yet.

KALSIOM SAS Alternatives & Competitors

View All Alternatives
KALSIOM SAS vs
Vastera
Vastera

Pioneering innovative treatments for cardiovascular and cancer diseases through novel redox signalin...

Series B
Biotechnology, Health Care
KALSIOM SAS vs
Tridek-One
Tridek-One France

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases

Venture round
12 employees
Biotechnology, Health Care
KALSIOM SAS vs
Oncofactor Corporation
Oncofactor Corporation

A Seattle-based innovator in cancer treatments, disrupting tumor-immune system signaling pathways.

Venture round
1 employees
Biotechnology, Health Care
View all alternatives

FAQ About KALSIOM SAS

Targeting calcium signaling to cure auto-immune diseases
KALSIOM SAS was founded in 2020.
KALSIOM SAS is headquartered in France.
KALSIOM SAS operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biotech, auto-immune diseases, B-cell dysfunction and monoclonal antibodies.
KALSIOM SAS has approximately 5 employees.
Top alternatives and competitors to KALSIOM SAS include Vastera, Tridek-One, Oncofactor Corporation, CytoDyn, Antharis Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KALSIOM SAS and Vastera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KALSIOM SAS, https://bouncewatch.com/company/kalsiom-sas, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes